Search

Tuesday’s CPI report served up a 0.02% miss, which sent the market into a tailspin. The Nasdaq fell more than 5%, its worst day since 2020. The S&P 500 Index fell 4.3%. And small caps? The S&P 600 fell 3.9%

In part three of our five-part series on forever stocks, Twitter (TWTR) is a long-term growth story despite its up-and-down chart.

With interest rates finally rising, bond investors face a real danger. Investing in the market’s best dividend-paying stocks is your best alternative.

There’s no doubt the word “bubble” gets more attention now than it did in better economic days. And the financial press has a vested interest in reporting on attention-getting topics—so warnings of bubbles are best taken with a grain of salt. But there’s one market today where there are certainly...

Before this week, we were seeing some minor divergences in the market—clearly many old world sectors like financials, transports and materials were doing well, but most growth stocks were meandering, with a few doing okay and others struggling. Overall, though, the evidence was relatively bullish. This week, though, definitely raises an eyebrow or two.

It’s been another constructive week for the market, though that’s not necessarily due to the major indexes, which are barely up (0.25% or so) since last Friday’s close.

Lots of earnings reports. Here are this week’s noteworthy pieces of news and price action in the Cabot Undervalued Stocks Advisor portfolios.

Perhaps most difficult for the average investor this year is that even the sectors and stocks considered to be safe have been decimated. When steady stocks such as Wal-Mart (down 30% year-to-date), ConocoPhillips (down 22% year-to-date) and Alcoa (down 40% year-to-date) are getting destroyed, it can be alarming. Can an investor who wants to own Nordstrom stock protect himself from the downside? Yes—by buying puts.

Each one of these three stocks is a conservative dividend payer with relatively low correlation to larger market moves.

The market was only open for three-and-a-half days last week, and it still managed to lose approximately 5% of its value. I don’t have to tell you that’s not good. I’ve been discussing the overall market a lot lately (if you didn’t catch last week’s market video before Thanksgiving, you can...

Since its debut less than three months ago, iQIYI stock has been one of the market’s hottest stocks. But has “the Netflix of China” become overcooked?

Writing covered calls is a great way to boost your yield on stocks you already own, and involves a lot less risk than most investors think.

This simple strategy for trading options can lead to steady income and the possibility for high share appreciation in blue-chip stocks.

After a dominant run in 2023, are any of the Magnificent Seven stocks still worth buying today? For most of them, the technicals say “yes.”

Find shelter from the storm so you can think calmly about your next investing move.

A quote by Jesse Livermore provides the basis for Cabot’s market timing indicators.

We’re sticking with our lean-bullish stance. Be sure to honor your stops and loss limits, and don’t forget to take partial profits if you get a good-sized profit over a couple of weeks. (Some commodity stocks fill that bill today) But you should hold your top performers and even look to put some money to work on this weakness.

It’s the beginning of August, high summer in New England, and a bit of summer fatigue is setting in. Summer in New England is short, so we try to pack half a year’s worth of cookouts, beach days, hikes, kayaking, sight-seeing and other outside recreation into three months. It’s fun, but the pace can be a bit frantic, especially as the season enters its third act. Frankly, all I want to do now is lie on a beach somewhere and read a book.

The initial panic has passed, and Wall Street is starting to process the real impacts of Brexit. Here’s what I think it means for the stock market today—and in the months and years to come.

Mere weeks after its failed merger with Pfizer (PFE), global pharmaceutical company Allergan PLC (AGN), maker of Viagra and Botox, announced a new $10 billion share repurchase authorization. Allergan plans to complete the $40 billion sale of its generic pharmaceutical business to Teva Pharmaceuticals by the end of this month. Following that, Allergan plans to immediately repurchase $4 billion to $5 billion of its stock over the subsequent four to six months. The company also plans to pay down debt with the proceeds of the Teva transaction. Let’s look at the stock’s valuation to see if it’s worth investing in.